Objection or Negotiation?
Know the Customer
Know the Deal
Fix the Representative
What Is the Real Problem?
100

A pharmacist says:


“I have never heard of your company, so I am not comfortable ordering.”


This is primarily an objection related to trust and uncertainty.

It is not negotiation yet.

100

What does MANT stand for in this workshop?

  • Money
  • Authority
  • Need
  • Timing
100

Name three negotiable variables other than price.


  • Quantity
  • Payment terms
  • Exclusivity
  • Bonus
100

Customer:


“Your price is high.”


Representative:


“But our quality is excellent.”



The representative defended before diagnosing the concern.

100

The pharmacist says:


“Your price is too high.”


Give one useful diagnostic question.

Acceptable answers

  • “High compared with which alternative?”
  • “Is the concern the purchase price, margin, or movement?”
  • “If movement were guaranteed, would price still be the main issue?”
  • “What makes the current price difficult for you?”
200

A pharmacist says:


“I like the product, and I can take 30 pcs, but I need you to arrange for the order it from your company directly  


This is negotiation.

The customer accepts the value but wants different terms.

200

A pharmacist likes the offer but says:


“I need to ask the doctor if he would prescribe it.”


Which MANT element was not properly explored?

Authority.

200

كمل الجملة:

كل الاوصاف نسبية ...........

حتى تجد لها نقطة معيارية

200

Customer:


“The competitor gives me more.”


Representative:


“Okay, I will see what I can do.”


What is wrong?

  • Accepted the customer’s framing.
  • Offered movement without gaining information.
  • Signalled weakness.
  • Negotiated against themselves.
  • Failed to ask for anything in return.
200

The pharmacist asks for a higher bonus.

After questioning, you discover that they are afraid the product will stay on the shelf(ينام)

What is the stated position, and what is the real interest?

Position:


“Give me a higher bonus.”


Interest:


“Reduce my commercial risk.”


300

A doctor says:


“Your product is expensive.”


The representative immediately offers a discount.

What mistake did the representative make?

They assumed that price was the real problem without diagnosing whether it was:

  • A value objection.
  • A comparison.
  • A budget issue.
  • A negotiation tactic.
  • A genuine commercial constraint.
300

A customer says:


“The price is high.”


After questioning, you discover they can afford it, but they do not want cash frozen in slow stock.

Which MANT element is most relevant?

Money, specifically cash flow and capital allocation.

Need may also be relevant because they need risk reduction.

300

The pharmacist asks for More bounce.

Give one conditional response.


“If we provide more bounce, would you be able to commit to a larger quantity

300

Customer:


“I want an extra bonus.”


Representative:


“How much do you want?”


What is the weakness?

The representative moved directly to numbers before understanding the reason, need, or value exchange.

300

A customer says:


“The competitor gives me more.”


Name three things you need to clarify before responding.

  • On what quantity?
  • With what payment terms?
  • Is the offer confirmed?
  • Is the competitor consistently available?
  • How fast does the competitor move?
  • What matters most about their offer?
  • Are the products truly comparable?
400

A pharmacist says:


“The product looks good, but I do not think it will move in my pharmacy.”


Is this selling, objection handling, or negotiation?


Primarily objection handling and value building.

The customer is not yet confident enough about movement.

400

Why is timing important in negotiation?

  • Why the customer wants to act now.
  • Whether there is urgency.
  • Seasonal or competitive pressure.
  • Changes in supply.
  • Changes in leverage.
  • Whether the negotiation is genuine or only exploratory.
400

A competitor offers a higher bonus but frequently goes out of stock.

How should you reframe the comparison?

Compare the total deal, not only the bonus:

  • Availability
  • Movement
  • Reorder frequency
  • Risk
  • Reliability
  • Net profit
400

Representative:


“I promise the product will sell very quickly.”


Why is this dangerous?

It raises expectations beyond the representative’s control.

If performance is lower than promised, trust falls even if the product performs reasonably well.

400

A pharmacist repeatedly says:


“Just give me your final offer.”


What should you avoid doing?

Avoid:

  • Giving the maximum concession immediately.
  • Negotiating against yourself.
  • Revealing your limit too early.
  • Treating urgency as proof that price is the only issue.
500

A loyal pharmacist says:


“We have worked together for a year. My purchasing volume has doubled, so I want to renegotiate the bonus.”


Why is this a real negotiation?

Because:

  • Value already exists.
  • There is an established relationship.
  • Both sides have reasons to continue.
  • The customer wants to redistribute value because their contribution or leverage changed.
500

A pharmacist says:


“If you do not improve the offer, I will buy from the competitor.”


What is the pharmacist’s possible BATNA?

Buying from the competitor.

But the representative should verify whether that alternative is:

  • Real.
  • Available.
  • Economically better.
  • Sustainable.
  • Comparable.
500

Create a quick Deal SWOT for this case:


Your product is more expensive, but it has strong demand and consistent availability. The competitor is cheaper and offers a higher bonus.


Strengths:

  • Strong demand.
  • Reliable availability.
  • Lower movement risk.

Weaknesses:

  • Higher price.
  • Lower visible bonus.

Opportunities:

  • Reorder commitment.
  • Product bundle.
  • Trial quantity.
  • Payment structure.
  • Long-term agreement.

Threats:

  • Competitor pricing.
  • Customer focusing only on bonus.
  • Pressure to create an unsustainable precedent.
500

Fix this full response:


“Doctor, our product is European, the quality is excellent, and I will ask my manager for more bonus.”



“I understand that the current offer does not yet feel commercially strong enough. Is the main concern the purchase price, the expected margin, or the risk of movement?”


Then, after diagnosis:


“If we can reduce the movement risk without changing the price, would you be open to proceeding?”


500

The pharmacist says:


“I want 10+3.”


Give a response that explores the need without rejecting the request.


“What does 10+3 help you achieve that the current offer does not?”


Other acceptable answers:


“Is the main concern margin, movement, or reducing the risk of the first order?”



“Help me understand why that specific structure is necessary for the deal.”


M
e
n
u